KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $12,036,000 | +63.8% | 782,554 | +81.5% | 0.01% | -17.6% |
| Q1 2014 | $7,348,000 | -32.6% | 431,201 | -48.8% | 0.02% | -29.2% |
| Q4 2013 | $10,910,000 | +20.9% | 842,468 | -5.7% | 0.02% | +14.3% |
| Q3 2013 | $9,027,000 | +88.5% | 893,770 | +39.4% | 0.02% | +90.9% |
| Q2 2013 | $4,790,000 | – | 641,233 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |